| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 352.851 | 394.319 | 415.004 | 472.415 | 551.609 | 610.905 | 626.513 | 695.245 | 826.328 | 882.914 |
| Total Income - EUR | 362.641 | 398.696 | 416.730 | 474.850 | 553.114 | 611.331 | 626.632 | 714.524 | 865.321 | 882.934 |
| Total Expenses - EUR | 379.028 | 380.379 | 396.384 | 437.515 | 528.898 | 573.737 | 591.617 | 687.887 | 857.383 | 882.155 |
| Gross Profit/Loss - EUR | -16.387 | 18.317 | 20.346 | 37.334 | 24.216 | 37.594 | 35.014 | 26.637 | 7.938 | 780 |
| Net Profit/Loss - EUR | -16.387 | 18.317 | 16.498 | 32.592 | 18.684 | 32.368 | 28.873 | 19.849 | 1.006 | 363 |
| Employees | 4 | 5 | 6 | 6 | 7 | 7 | 7 | 8 | 9 | 8 |
Check the financial reports for the company - Bionifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 77.056 | 69.055 | 65.365 | 58.589 | 48.208 | 41.028 | 32.551 | 25.687 | 22.396 | 22.279 |
| Current Assets | 86.031 | 56.797 | 56.105 | 96.087 | 119.133 | 132.413 | 146.845 | 156.061 | 214.725 | 322.337 |
| Inventories | 28.860 | 19.326 | 23.546 | 45.918 | 67.822 | 63.918 | 73.773 | 78.211 | 122.012 | 113.256 |
| Receivables | 48.566 | 25.909 | 29.653 | 42.842 | 46.486 | 55.203 | 53.718 | 63.491 | 76.353 | 46.572 |
| Cash | 8.606 | 11.563 | 2.906 | 7.328 | 4.825 | 13.292 | 19.355 | 14.359 | 16.360 | 102.199 |
| Shareholders Funds | -22.631 | -4.084 | 12.483 | 11.492 | 29.954 | 61.754 | 89.258 | 105.744 | 66.741 | 55.674 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 185.927 | 129.958 | 108.986 | 143.184 | 137.388 | 111.790 | 90.138 | 76.004 | 170.380 | 288.942 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Bionifarm Srl